NDC 69097-890 Lanreotide Acetate
Injection Subcutaneous - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 69097 - Cipla Usa Inc.
- 69097-890 - Lanreotide Acetate
Product Packages
NDC Code 69097-890-67
Package Description: 1 SYRINGE in 1 CARTON / .3 mL in 1 SYRINGE
Product Details
What is NDC 69097-890?
What are the uses for Lanreotide Acetate?
What are Lanreotide Acetate Active Ingredients?
Which are Lanreotide Acetate UNII Codes?
The UNII codes for the active ingredients in this product are:
- LANREOTIDE ACETATE (UNII: IEU56G3J9C)
- LANREOTIDE (UNII: 0G3DE8943Y) (Active Moiety)
What is the NDC to RxNorm Crosswalk for Lanreotide Acetate?
- RxCUI: 749811 - lanreotide 60 MG in 0.2 ML Prefilled Syringe
- RxCUI: 749811 - 0.2 ML lanreotide 300 MG/ML Prefilled Syringe
- RxCUI: 749811 - lanreotide 60 MG per 0.2 ML (as lanreotide acetate) Prefilled Syringe
- RxCUI: 749814 - lanreotide 120 MG in 0.5 ML Prefilled Syringe
- RxCUI: 749814 - 0.5 ML lanreotide 240 MG/ML Prefilled Syringe
Which are the Pharmacologic Classes for Lanreotide Acetate?
* Please review the disclaimer below.
Patient Education
Lanreotide Injection
Lanreotide injection is used to treat people with acromegaly (condition in which the body produces too much growth hormone, causing enlargement of the hands, feet, and facial features; joint pain; and other symptoms) who have not successfully, or cannot be treated with surgery or radiation. Lanreotide injection is also used to treat people with neuroendocrine tumors in the gastrointestinal (GI) tract or the pancreas (GEP-NETs) that have spread or cannot be removed by surgery. Lanreotide injection is in a class of medications called somatostatin agonists. It works by decreasing the amounts of certain natural substances produced by the body.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".